News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hsu Frank J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 16,354 shares
@ $0
Disposed/sold 224,872 options to buy
@ $4.79, valued at
$1.1M
Disposed/sold 27,000 options to buy
@ $2.46, valued at
$66.4k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 27,000 options to buy
@ $2.46, valued at
$66.4k
|
|
| 08/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/31/2020 |
4/A
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 150,000 options
@ $5.64, valued at
$846k
|
|
| 07/31/2020 |
4/A
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 16,280 options
@ $3.33, valued at
$54.2k
|
|
| 03/18/2020 |
4
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 16,280 options
@ $3.33, valued at
$54.2k
|
|
| 08/28/2019 |
4
| Hsu Frank J. (Chief Medical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 150,000 options
@ $5.64, valued at
$846k
|
|
| 08/28/2019 |
3
| Hsu Frank J. (Chief Medical Officer) has filed a Form 3 on Oncternal Therapeutics, Inc. |
|
|